Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm

Table 1

Characteristics of the entire cohort.

	𝑁=70	%
Age	35,5 (20–73)	—
Gender (F/M)	66/4	94.3/5.7
Size	2.0 (0.2–6.0)	—
Histology
Papillary	56	80
Follicular	14	20
Unifocal	59	84.3
Multifocal	11	15.7
T
T1a	16	22.9
T1b	26	37.1
T2	16	22.9
T3	12	17.1
T4	0
N
Nx	44	62.9
N0	14	20
N1a	5	7.1
M0	0
TNM
Stage I	59	84.3
Stage II	7	5.7
Stage III	4	10
Stage IV	0
ATA
Low	49	70
Intermediate	21	30
High	0	0
Follow-up	12 (3–28)	—
Additional therapy	10	14.3
Time to additional therapy (years)	11 (3–24)	—
First suppressed Tg post-op	4.23 (<0.5–46)	—
Trend of Tg
Decrease	29	41.4
Increase	18	25.7
Stable	23	32.9
Final status
NSED without additional therapy	60	85.7
NSED with additional therapy	9	12.9
Recurrent/persistent disease	1	1.4